Democratizing hedge fund level analysis tools for everyone
Name | Kimia Farma Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 03-31-25 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Bio Farma (Persero) | 89.82 | 89.82 |
Public < 5% | 10.18 | 10.18 |
Others | 0.01 | 0.0 |
Negara Republik Indonesia | 0.0 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Retail | 47.8% | 52.2% |
Distribution | 45.6% | 39.6% |
Manufacture | 3.8% | 3.4% |
Other | 2.9% | 4.9% |
Others | -0.0% | -0.0% |
Region | 2022 | 2021 |
---|---|---|
Netherlands | 0.0% | 0.0% |
Saudi Arabia | 0.0% | 0.0% |
China | 0.0% | 0.0% |
Indonesia | 98.9% | 98.6% |
Overseas | 1.1% | 1.4% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 0.33 | # 5 / 15 |
EV_EBITDA | 38.94 | # 12 / 15 |
PER | -7.05 | --- / 15 |
PBV | 0.86 | # 3 / 15 |
DER | 3.39 | # 12 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | -4.7 | --- / 15 |
ROA % | -2.7 | --- / 15 |
ROE % | -12.2 | --- / 15 |
Year | DPS | Yield [%] |
---|---|---|
2022 | 16.3 | 1.5 |
2021 | 1.3 | 0.1 |
2019 | 15.0 | 1.2 |
Timeframe | Performance |
---|---|
1W % | -3.7 |
1Mo % | -6.4 |
3Mo % | 10.0 |
1Yr % | -15.6 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
KAEF | -7.05 | 2.84 T | 14.19 T | 8.67 T | 365 B | -409 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |